As a vital part of the medical community, we at BioCryst accept proposals for medical education grants, sponsorship requests, charitable contributions and/or donations, and patient advocacy charitable contributions.
We accept submission requests for:
Medical Education
Support for independent accredited or unaccredited medical education activities or education directed to healthcare professionals, healthcare organizations, patient organizations, patients, or other members of the healthcare community.
Grant Requests
Support for activities and programs not related to charitable donations, medical education, or sponsorship opportunities. These funding opportunities may include (but are not limited to): support of an organization’s mission, professional development, publications, insight generation (eg, unmet needs, burden of disease), resource development, and other nonmedical education initiatives. BioCryst does not expect to receive any benefit, consideration, or service in return.
Sponsorship Requests
Funding to an eligible entity (including patient advocacy organizations or healthcare organizations) for events or activities in exchange for tangible benefits from the funding recipient, such as the opportunity for BioCryst advertisements at an event or activity, exhibit space at an event, admission to certain events, etc.
Charitable Donations
Funding or other support (including equipment or free products) provided by BioCryst to a not-for-profit, tax-exempt charitable organization to support education, outreach, or similar purposes. The current areas of focus for BioCryst are to promote health-related programs outside of BioCryst therapeutic areas and certain charitable events in support of community health.
We are proud to Support Pioneering advances in Angioedema Research and Knowledge (SPARK) with the BioCryst SPARK Award, a $50,000 grant supporting young investigators in independent preclinical and/or clinical research that advances the science of angioedema. Click here to learn more about the SPARK Award.
Areas of interest
Medical – Hereditary Angioedema (HAE):
Defining overall disease burden for patients, families and others impacted by HAE/ bradykinin-mediated angioedema
- Understanding the impact of HAE disease and unmet needs of underrepresented patient populations
- Understanding HAE disease and treatment burden on quality of life (including physical and mental health impacts) on patients and caregivers
- Healthcare utilization costs and financial burden of HAE
- Evolution of understanding and classification of bradykinin-mediated angioedemas (i.e., HAE normal C1-INH, hereditary, acquired, contact pathway mutations)
Redefining HAE/bradykinin-mediated angioedema disease management goals and optimal outcomes
- Diagnosis, management, and outcome measures of success for patients living with HAE/bradykinin-mediated angioedema
- Review of treatment guidelines/recommendations
- Individualized support and shared decision making to improve patient experience and long-term goals for success
- Options on switching from previous prophylaxis, on-demand treatment, and patient-specific considerations for approved therapies (individualized approach)
- Diagnosis and management of pediatric patients with HAE/bradykinin-mediated angioedema
Patient Advocacy:
Local, regional, and global patient advocacy focused on:
- Hereditary Angioedema (HAE)
- Netherton Syndrome
- Broader rare disease community